Lisa S. Kahalley
Baylor College of Medicine
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Lisa S. Kahalley.
Journal of Clinical Oncology | 2016
Lisa S. Kahalley; M. Douglas Ris; David R. Grosshans; M. Fatih Okcu; Arnold C. Paulino; Murali Chintagumpala; Bartlett D. Moore; Danielle Guffey; Charles G. Minard; Heather Stancel; Anita Mahajan
PURPOSE Compared with photon radiation (XRT), proton beam radiation therapy (PBRT) reduces dose to normal tissues, which may lead to better neurocognitive outcomes. We compared change in intelligence quotient (IQ) over time in pediatric patients with brain tumors treated with PBRT versus XRT. PATIENTS AND METHODS IQ scores were available for 150 patients (60 had received XRT, 90 had received PBRT). Linear mixed models examined change in IQ over time since radiation therapy (RT) by RT group, controlling for demographic/clinical characteristics. Craniospinal and focal RT subgroups were also examined. RESULTS In the PBRT group, no change in IQ over time was identified (P = .130), whereas in the XRT group, IQ declined by 1.1 points per year (P = .004). IQ slopes did not differ between groups (P = .509). IQ was lower in the XRT group (by 8.7 points) versus the PBRT group (P = .011). In the craniospinal subgroup, IQ remained stable in both the PBRT (P = .203) and XRT groups (P = .060), and IQ slopes did not differ (P = .890). IQ was lower in the XRT group (by 12.5 points) versus the PBRT group (P = .004). In the focal subgroup, IQ scores remained stable in the PBRT group (P = .401) but declined significantly in the XRT group by 1.57 points per year (P = .026). IQ slopes did not differ between groups (P = .342). CONCLUSION PBRT was not associated with IQ decline or impairment, yet IQ slopes did not differ between the PBRT and XRT groups. It remains unclear if PBRT results in clinically meaningful cognitive sparing that significantly exceeds that of modern XRT protocols. Additional long-term data are needed to fully understand the neurocognitive impact of PBRT in survivors of pediatric brain tumors.
Pediatric Blood & Cancer | 2012
Lisa S. Kahalley; Leslie A. Robinson; Vida L. Tyc; Melissa M. Hudson; Wendy Leisenring; Kayla Stratton; Anne C. Mertens; Lonnie K. Zeltzer; Leslie L. Robison; Pamela S. Hinds
Few studies have examined risk factors for smoking among adolescent survivors of childhood cancer. The present study reports on the rate of smoking and identifies factors associated with smoking in a sample of adolescent survivors from the Childhood Cancer Survivor Study (CCSS).
Psycho-oncology | 2012
Lisa S. Kahalley; Stephanie J. Wilson; Vida L. Tyc; Heather M. Conklin; Melissa M. Hudson; Shengjie Wu; Xiaoping Xiong; Heatlher H. Stancel; Pamela S. Hinds
To describe the psychological needs of adolescent survivors of acute lymphoblastic leukemia (ALL) or brain tumor (BT), we examined the following: (i) the occurrence of cognitive, behavioral, and emotional concerns identified during a comprehensive psychological evaluation and (ii) the frequency of referrals for psychological follow‐up services to address identified concerns.
Psycho-oncology | 2013
Lisa S. Kahalley; Heather M. Conklin; Vida L. Tyc; Melissa M. Hudson; Stephanie J. Wilson; Shengjie Wu; Xiaoping Xiong; Pamela S. Hinds
Acute lymphoblastic leukemia (ALL) and brain tumor (BT) survivors are at risk for post‐treatment IQ declines. The extent to which lower scores represent global cognitive decline versus domain‐specific impairment remains unclear. This study examined discrepancies between processing speed and estimated IQ (EIQ) scores and identified clinical characteristics associated with score discrepancies in a sample of pediatric cancer survivors.
Pediatric Blood & Cancer | 2012
Katherine H. Moyer; Victoria W. Willard; Alan M. Gross; Kelli L. Netson; Jason M. Ashford; Lisa S. Kahalley; Shengjie Wu; Xiaoping Xiong; Heather M. Conklin
The cognitive late effects experienced by many survivors of pediatric acute lymphoblastic leukemia (ALL) and brain tumors are well‐established. The most commonly reported deficit is difficulty with attention. Problems with social functioning have also been identified, but their relationship with cognitive functioning is not well understood. This multi‐site, cross‐sectional study aimed to examine the impact of attention on social functioning.
Journal of Clinical and Experimental Neuropsychology | 2014
Amanda L. Winter; Heather M. Conklin; Vida L. Tyc; Heather Stancel; Pamela S. Hinds; Melissa M. Hudson; Lisa S. Kahalley
Background: Survivors of pediatric brain tumors (BT) and acute lymphoblastic leukemia (ALL) are at risk for neurocognitive late effects related to executive function. Procedure: Survivors of BT (48) and ALL (50) completed neurocognitive assessment. Executive function was compared to estimated IQ and population norms by diagnostic group. Results: Both BT and ALL demonstrated relative executive function weaknesses. As a group, BT survivors demonstrated weaker executive functioning than expected for age. Those BT survivors with deficits exhibited a profile suggestive of global executive dysfunction, while affected ALL survivors tended to demonstrate specific rapid naming deficits. Conclusion: Findings suggest that pediatric BT and ALL survivors may exhibit different profiles of executive function late effects, which may necessitate distinct intervention plans.
Pediatric Blood & Cancer | 2011
Lisa S. Kahalley; Heather M. Conklin; Vida L. Tyc; Stephanie J. Wilson; Pamela S. Hinds; Shengjie Wu; Xiaoping Xiong; Melissa M. Hudson
Post‐treatment attention problems experienced by pediatric cancer survivors have been described as similar to symptoms of Attention‐Deficit/Hyperactivity Disorder (ADHD) experienced in physically healthy children. Accordingly, the objectives of this study were to: (a) estimate the rate of occurrence of ADHD and secondary ADHD (SADHD) in a sample of pediatric cancer survivors, (b) compare the rate of ADHD/SADHD among survivors to the prevalence of ADHD in the general population, and (c) examine clinical correlates of ADHD/SADHD in this sample.
Journal of Pediatric Oncology Nursing | 2014
Jennifer A. Hansen; Heather Stancel; Lisa M. Klesges; Vida L. Tyc; Pamela S. Hinds; Shengjie Wu; Melissa M. Hudson; Lisa S. Kahalley
Objectives: Elevated body mass index (BMI) has been reported in pediatric cancer survivors. It is unclear whether this is related to altered energy intake (via disordered eating), decreased energy expenditure (via limited exercise), or treatment-related direct/indirect changes. The aims of this study are to describe the occurrence of overweight and obesity, exercise frequency, and the extent of disordered eating patterns in this sample of survivors, and to examine relationships among BMI, eating patterns, exercise frequency, and demographic and disease and treatment-related variables to identify those survivors most at risk for overweight/obesity. Methods: This cross-sectional study recruited 98 cancer survivors (50 acute lymphoblastic leukemia [ALL], 48 brain tumor [BT]), aged 12 to 17 years and ≥12 months posttreatment from a large pediatric oncology hospital. Survivors completed health behavior measures assessing disordered eating patterns and physical activity. Clinical variables were obtained through medical record review. Univariate analyses were conducted to make comparisons on health behaviors by diagnosis, gender, treatment history, and BMI category. Results: Fifty-two percent of ALL survivors and 41.7% of BT survivors were classified as overweight/obese. Overweight/obesity status was associated with higher cognitive restraint (odds ratio = 1.0; 95% confidence interval = 1.0-1.1). Only 12% of ALL survivors and 8.3% of BT survivors met Centers for Disease Control and Prevention guidelines for physical activity. Males reported more physical activity, t(96) = 2.2, P < .05. Conclusions: Overweight/obese survivors may attempt to purposefully restrict their food intake and rely less on physiological cues to regulate consumption. Survivors should be screened at follow-up for weight-related concerns.
Nicotine & Tobacco Research | 2010
Lisa S. Kahalley; Leslie A. Robinson; Vida L. Tyc; Melissa M. Hudson; Wendy Leisenring; Kayla Stratton; Lonnie K. Zeltzer; Ann C. Mertens; Leslie L. Robison; Pamela S. Hinds
INTRODUCTION Previous research has suggested that childhood cancer survivors initiate smoking at rates approaching those of healthy individuals, even though smoking presents unique risks to survivors. The present study explores whether the attentional and executive functioning (EF) deficits associated with cancer and treatment place survivors of childhood cancer at increased risk for smoking. METHODS Data from the Childhood Cancer Survivor Study were examined to identify concurrent and longitudinal correlates of tobacco use. We explored whether childhood attention problems and adulthood executive dysfunction were associated with smoking among adult survivors of childhood cancer. RESULTS Childhood attention problems emerged as a striking predictor of adult smoking nearly a decade later on average. Nearly half (40.4%) of survivors who experienced attention problems in childhood reported a history of smoking, a significantly higher rate of ever smoking, than reported by those without childhood attention problems (relative risk [RR] = 1.53, 95% CI = 1.31-1.79). Furthermore, they were nearly twice as likely to be current smokers in adulthood compared with those without childhood attention problems (RR = 1.71, 95% CI = 1.38-2.11). Similar associations were found between components of adult executive dysfunction and adult smoking. DISCUSSION Childhood cancer and treatment are associated with subsequent deficits in attention and EF. Early detection of these deficits will allow clinicians to identify patients who are at increased risk for smoking, an important step in promoting and maintaining health in this medically vulnerable population.
Journal of Cancer Survivorship | 2011
Lisa S. Kahalley; Vida L. Tyc; Stephanie J. Wilson; Jenna Nelms; Melissa M. Hudson; Shengjie Wu; Xiaoping Xiong; Pamela S. Hinds
IntroductionThe present study examines behavioral and psychosocial factors associated with smoking intentions and experimentation among adolescent survivors of pediatric cancer.MethodsAdolescent survivors of brain tumor and acute lymphoblastic leukemia (n = 99) provided information about their smoking histories and their intentions to smoke in the future. Behavior rating scales were completed by survivors, parents, and teachers.ResultsPast experimentation with smoking and higher levels of self-reported aggression were associated with intentions to smoke in the future (OR = 4.18, 95% CI 1.02–17.04, and OR = 1.08, 95% CI 1.01–1.15, respectively), while teacher-ratings of inattention in the classroom were negatively associated with intentions to smoke (OR = 0.94, 95% CI.88–.99), all p < .05. Experimentation with smoking was more likely among older survivors (OR = 1.76, 95% CI 1.16–2.66, p < .01) and those whose parents had divorced (OR = 4.40, 95% CI 1.21–16.06, p < .05).DiscussionA concerning minority of adolescent survivors have clear intentions to smoke, a behavior that adds to their overall health risk. Smoking intentions and experimentation are important precursors to regular smoking. Prevention efforts are needed to interrupt the progression from intentions and experimentation to established smoking and nicotine dependence in this medically vulnerable population.Implications for cancer survivorsAssessment of an adolescent’s history of parental divorce, past experimentation with smoking, and aggressive behavior will identify those survivors who are likely to consider smoking in the future. Screening for these characteristics will allow clinicians to be more vigilant in health promotion.